William Humphries

William Humphries is a Senior Lecturer and Course Director at the Faculty of Engineering, Agri-tech and the Environment, Anglia Ruskin University Peterborough. He holds a PhD in Biochemistry from the University of Kent and has extensive industry experience at Spirogen Limited (now AstraZeneca) and Mologic Limited (now Global Access Diagnostics), focusing on anti-cancer therapeutics and diagnostic technologies.

His educational background includes:

• BSc (Hons) Biology, Kingston University
• MRes in Biochemistry, Kingston University
• PhD in Biochemistry, University of Kent
• PGCE in Secondary Sciences, Edgehill University
• PGCertHE in Higher Education, Anglia Ruskin University

Dr. Humphries' research integrates cell and molecular biology with medical diagnostics, emphasizing protein expression systems, antibody engineering, and point-of-care device development. His work spans model organisms (Arabidopsis, Lymnaea, Pichia, E. coli) and human cell cultures, targeting anti-cancer applications and novel diagnostic platforms.

His publications demonstrate an evolution from fundamental invertebrate immunology research (2003 MAPK/PKC signaling study) to translational veterinary oncology (2016 canine CD20 antibody development), reflecting his interdisciplinary approach to bridging basic science and clinical applications.

Professional recognitions include:

• Fellow of the Higher Education Academy
• Chartered Biologist status
• Membership in the Royal Society of Biology

As Course Director for Biomedical Sciences, Dr. Humphries oversees curriculum development and student training, leveraging his industrial R&D background to enhance practical education. He actively seeks to establish a research group in anti-cancer drug discovery and medical diagnostics, building on his expertise in molecular techniques and diagnostic device engineering.